Research Article
Low Expression of FFAR2 in Peripheral White Blood Cells May Be a Genetic Marker for Early Diagnosis of Acute Myocardial Infarction
Table 3
Baseline data (which showed differences between the test and the control groups).
| | Data category | AMI group (n = 113) | Control (n = 94) | t/x2/z | value |
| | Age (years) | 64.10 ± 11.23 | 57.88 ± 10.42 | 4.10 | 0.00 | | Type 2 diabetes mellitus (%) | 26 (29.89) | 12 (15.38) | 5.07 | 0.02 | | Fasting blood glucose (mmol/l) | 6.56 (5.32–9.43) | 5.39 (5.03–6.18) | −4.24 | 0.00 | | HDL-C (mmol/l) | 0.95 (0.81–1.13) | 1.05 (0.92–1.24) | −2.24 | 0.03 | | Hypoglycemic drug (%) | 25 (22.12) | 8 (8.51) | 7.695 | 0.01 |
|
|
AMI = acute myocardial infarction; HDL-C = high-density lipoprotein cholesterol.
|
